Who We Are

What We Do

Events

Join Now

 
ForYourBenefit-SpecialEdition-Vacc image

At last week’s ACIP meeting, the committee voted to change its long-standing recommendation for giving the hepatitis B vaccine at birth. The new guidance keeps the birth-dose recommendation for babies whose mothers test positive or whose status isn’t known. But for babies whose mothers test negative, ACIP now suggests that parents and clinicians decide together, with the option to start the vaccine at the 1- to 2-month visit instead of right after birth.

hepB-EBG_Page_1-scaled image

This change was made without new evidence showing that delaying the vaccine is safer or more effective, and it raises concerns about the risks of delaying or missing vaccination. Major medical groups — including the American Medical Association (AMA), the American Academy of Family Physicians (AAFP), and the American College of Obstetricians and Gynecologists (ACOG) — say the existing evidence still supports giving the vaccine at birth and continue to strongly recommend it.

hepB-EBG_Page_2-scaled image

For now, nothing changes immediately. The recommendation must first be reviewed and approved by the CDC director before it becomes official and is added to CDC’s immunization schedules. After that, states, health systems, insurers, and providers may update their policies. Employers may face differing federal and state requirements which they will have to navigate. More guidance is expected in the coming weeks.


 

// CONNECT WITH US //

Facebook  Linkedin